Stock Ratings / Health Care / POCI / dividends

ECOR (38) QTI (38) OM (35) HYPR (45) ⌘ Pro Terminal →

Precision Optics Corporation Inc. (POCI) Dividend Safety Gauge & 10-Year DRIP Compounder

$4.59 +5.76% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $4.63

Precision Optics Corporation Inc. (POCI) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $50.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $4.63 (+0.85%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.7% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-10.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for POCI)Realized 20D OHLCV Swing Band: ±8.2%

Deterministic 5-Pillar Attribution (34/100 Composite)

🔍 WHY POCI SCORES 34/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (35% of score)

20D Institutional Volume Accumulation (±8.2% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+12/20 pts (35% of score)

FRED Regime × Technicals: 40% of 52W Range • RSI-14 at 60.4 (BULLISH MOMENTUM)

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$4.58-5.7% Next Q

Q2 (-2Q)

Grade E$4.32+0.2% Next Q

Q3 (-1Q)

Grade E$4.33+6% Next Q

Current

Grade E$4.59-8.7% Hist 90D α

Trajectory: E (26) → E (34)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a POCI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While POCI currently carries a cautious 34/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.42) and Max Pain ($4.82) forces dealer call-delta covering toward $6.46.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $POCI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “POCI Beats Next Quarter EPS Consensus (Dec 28, 2026) & Holds Above 200D SMA”

YES 34%NO 66%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

0.6% Total Yield

0% Cash ($0.00/yr) + 0.6% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $102/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.1K

Yr 2

$11.7K

Yr 3

$12.4K

Yr 4

$13.1K

Yr 5

$13.8K

Yr 6

$14.5K

Yr 7

$15.3K

Yr 8

$16.2K

Yr 9

$17.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring POCI)

✓Walkthrough of POCI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

POCI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +8.51%⚡ TESTING RESISTANCE

2026-10-30O $4.60H $4.65L $4.51C $4.59VOL 11.2K

RES: $4.68SUP: $4.01SMA50: $4.42SMA200: $4.62

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

POCI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 POCI Butterfly Map → + Track POCI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -0.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on POCI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for POCI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for POCI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (POCI)

Health Care Rank #848 of 1016 ⚔️ ECOR vs POCI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (POCI vs. ECOR, QTI, OM, HYPR)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Precision Optics Corporation Inc. (POCI) ranks #848 by composite RQD confidence (34/100, grade E) and #751 by equity capitalization ($50.5M). Within this direct 5-issuer industry benchmark cohort, POCI leads on earnings valuation at N/A trailing P/E, while OM leads on capital efficiency and profitability with -28.0% ROIC and 39.1% gross margin. HYPR currently holds the highest overall quantitative score in the immediate peer group at 45/100 (D) compared with POCI at 34/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
POCI ACTIVE Precision Optics Corporation Inc.	E	34/100	—	17.8%	-35.0%	+5.76%	$50.5M	Benchmark Subject
ECOR electroCore Inc.	D-	38/100	—	86.8%	-35.0%	-3.68%	$73.1M	/ecor-vs-poci →
QTI QT Imaging Holdings Inc.	D-	38/100	—	45.4%	-35.0%	-3.07%	$32.3M	/qti-vs-poci →
OM Outset Medical Inc.	D-	35/100	—	39.1%	-28.0%	-3.46%	$78.8M	/om-vs-poci →
HYPR Hyperfine Inc. (Class A)	D	45/100	—	49.8%	-35.0%	-5.23%	$78.9M	/hypr-vs-poci →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-06-30 • CIK 0000867840

In its most recent audited fiscal period (FY2025, filed 2025-06-30), Precision Optics Corporation Inc. (POCI) reported GAAP revenue of $19.1M (-0.1% vs. FY2024 revenue of $19.1M , and -9.3% cumulative change since FY2023) , GAAP net income of -$5.8M, operating cash flow of -$3.4M, and free cash flow of -$3.6M (-22.6% YoY). On the balance sheet, POCI closed FY2025 with $22.9M in total assets against $1.0M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-06-30	$19.1M	-$5.8M	-$3.4M	-$3.6M	$22.9M	$1.0M
FY2024 (FY)	2024-06-30	$19.1M	-$3.0M	-$2.7M	-$3.0M	$17.5M	$1.6M
FY2023 (FY)	2023-06-30	$21.0M	-$144.6K	-$81.1K	-$81.1K	—	—

3. POCI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is POCI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Precision Optics Corporation Inc. (NASDAQ: POCI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $4.59 (+5.76% 1D, market cap $50.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 12/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, POCI ranks #848 in composite RQD confidence.

How does POCI compare to ECOR and QTI in the Health Care sector?

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), POCI carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 17.8%, and ROIC of -35.0%. By comparison, ECOR (electroCore Inc.) holds a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $73.1M) and QTI (QT Imaging Holdings Inc.) posts a D- grade (38/100 RQD, P/E N/A, ROIC -35.0%, cap $32.3M). Among the 5-stock peer group, POCI leads on earnings multiple (N/A) while OM leads on capital efficiency (-28.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for POCI?

Per POCI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-06-30, CIK 0000867840), Precision Optics Corporation Inc. generated $19.1M in revenue (-0.1% YoY), -$5.8M in net income, and -$3.6M in free cash flow against $22.9M in total assets and $1.0M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is POCI trading relative to its 50-day, 200-day, and 52-week technical levels?

POCI last traded at $4.59 (+5.76% on volume of 20,580 shares), positioning the stock +3.85% above its 50-day simple moving average ($4.42) and -0.65% below its 200-day simple moving average ($4.62). Across its 52-week range of $3.55 to $6.15, POCI sits at the 40.0% percentile with a 14-day RSI of 60.4 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.2% ($4.21 to $4.97).

POCI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does POCI pay a dividend and is it safe?

Precision Optics Corporation Inc. (POCI) offers a 0% cash dividend yield ($0.00 annualized) and 0.6% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: POCI RQD Cockpit POCI 12M Forecast POCI Earnings & Move POCI Dividends & DRIP POCI Insiders & 13F POCI Whale Options POCI Profit Sankey POCI News & Why